Serving leading biopharmaceutical companies globally:

Last Updated: January 25, 2020

DrugPatentWatch Database Preview

NUCALA Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Tradename: NUCALA

Patents:	31
Applicants:	2
BLAs:	2
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for NUCALA

Recent Clinical Trials for NUCALA

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
University of North Carolina, Chapel Hill	Phase 2
Northwestern University	Phase 2
University of Utah	Phase 2

See all NUCALA clinical trials

Pharmacology for NUCALA

Mechanism of Action	Interleukin-5 Antagonists

Patent Text Search: US Patents for NUCALA

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Glaxosmithkline Llc	NUCALA	mepolizumab	INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER	125526	001	2015-11-04	Start Trial	Knopp Biosciences LLC (Pittsburgh, PA)	2033-08-13	RX	Orphan	search
Glaxosmithkline Llc	NUCALA	mepolizumab	INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER	125526	001	2015-11-04	Start Trial	DS BIOPHARMA LIMITED (Dublin, IE)	2035-05-13	RX	Orphan	search
Glaxosmithkline Llc	NUCALA	mepolizumab	INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER	125526	001	2015-11-04	Start Trial	CureVac AG (Tubingen, DE)	2032-02-15	RX	Orphan	search
Glaxosmithkline Llc	NUCALA	mepolizumab	INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER	125526	001	2015-11-04	Start Trial	Knopp Biosciences LLC (Pittsburgh, PA)	2033-08-13	RX	Orphan	search
Glaxosmithkline Llc	NUCALA	mepolizumab	INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER	125526	001	2015-11-04	Start Trial	Patheon Softgels, Inc. (High Point, NC)	2035-06-15	RX	Orphan	search
Glaxosmithkline Llc	NUCALA	mepolizumab	INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER	125526	001	2015-11-04	Start Trial	PRAIRIE PHARMACEUTICALS LLC (Bethesda, MD)	2030-02-08	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for NUCALA

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Serbia	52210	Start Trial
Colombia	6160229	Start Trial
Hungary	E026237	Start Trial
Japan	2013209381	Start Trial
Russian Federation	2616000	Start Trial
New Zealand	614852	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

Johnson and Johnson

Harvard Business School

Colorcon

Express Scripts

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.